GTC Biotherapeutics (fka GTCB)

[floblu14]

>I was surprised that Atryn US would not be much of an economic win by itself if we were to gain approval by the FDA<

>Do you think we would need a partner in the US to effectively market Atryn for HD?<

Dr. Cox's statement from 2Q07 CC (Dew's post - READ ME FIRST)

Notice the words "significantly underserved market"

>Effective partnering will be important in maximizing and exploiting the market opportunity for ATryn in the significantly underserved market. Remember there is only a single plasma derived product in the US market and sales have been constrained over the years by lack of product availability. A large, well financed, commercial partner is an important objective for GTC to achieve the market presence and opportunity which we believe ATryn represents, and I look forward to updating you on our progress.<
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21999558